PCR178 Burden of Chronic Hand Eczema: A Snapshot of Patient Reported Outcomes Collected at Screening in a Phase 2B Trial with Delgocitinib

Abstract

Chronic hand eczema (CHE) is a burdensome multifactorial inflammatory skin disorder. Here we describe the burden of CHE, by disease severity, on patients’ quality of life using two patient reported outcomes (PROs) completed at screening: (1) Dermatology Life Quality Index (DLQI); and (2) EuroQoL 5-dimension health questionnaire 5-level (EQ-5D-5L).